A spontaneous intramural hematoma of the bowel presenting as obstruction in a child receiving low-molecular-weight heparin

Peter H. Shaw, Sarangarajan Ranganathan, Barbara Gaines

Research output: Contribution to journalArticlepeer-review

Abstract

Low-molecular-weight heparin (LMWH) is a safe and effective alternative to unfractionated heparin and coumadin in the treatment and prophylaxis of thrombosis in children. When compared with these more established anticoagulants, it is easier to achieve therapeutic levels and the incidence of hemorrhagic complications is equivalent or lower. In children there is less published experience than in adults, but the low frequency of significant bleeding appears to be similar. The authors describe a child on therapeutic doses of LMWH for a deep vein thrombosis who spontaneously developed an intramural hemorrhage in his small bowel, leading to infarction and a partial bowel resection.

Original languageEnglish (US)
Pages (from-to)558-560
Number of pages3
JournalJournal of Pediatric Hematology/Oncology
Volume27
Issue number10
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Keywords

  • Hemorrhage
  • Low-molecular-weight heparin
  • Thrombophilia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'A spontaneous intramural hematoma of the bowel presenting as obstruction in a child receiving low-molecular-weight heparin'. Together they form a unique fingerprint.

Cite this